Previous Close | 5.17 |
1-Year Change | -73.49% |
6-Months Change | -56.11% |
3-Months Change | -37.56% |
Moving Avg (50d) | 6.6986 |
Moving Avg (200d) | 11.8686 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 316.3M |
Beta (3-Years) | 1.22 |
Revenue Growth (ttm) | 837.52% |
Net Profit Margin (ttm) | -317.29% |
Return On Assets (ttm) | -54.24% |
EPS (ttm) | -5.57 |
PE Ratio (ttm) | -0.93 |
Dividend Yield | 0% |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |